Janux Therapeutics
JANX
JANX
216 hedge funds and large institutions have $3.43B invested in Janux Therapeutics in 2024 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 80 increasing their positions, 43 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
66% more capital invested
Capital invested by funds: $2.07B → $3.43B (+$1.36B)
35% more funds holding
Funds holding: 160 → 216 (+56)
23.5% more ownership
Funds ownership: 87.46% → 110.97% (+24%)
Holders
216
Holding in Top 10
10
Calls
$37.7M
Puts
$19.7M
Top Buyers
| 1 | +$64.2M | |
| 2 | +$59.7M | |
| 3 | +$56.2M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$55.6M |
| 5 |
Holocene Advisors
New York
|
+$54.3M |
Top Sellers
| 1 | -$26.8M | |
| 2 | -$22M | |
| 3 | -$6.23M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$5.01M |
| 5 |
State Street
Boston,
Massachusetts
|
-$4.99M |